Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Gerresheimer FY26 Q1 adjusted EBITDA drops 18.52% to EUR 66 million; revenue rises 0.96% to EUR 524 million

Gerresheimer FY26 Q1 adjusted EBITDA drops 18.52% to EUR 66 million; revenue rises 0.96% to EUR 524 million

ReutersReuters2026/08/27 07:20
  • Gerresheimer posted Q1 2026 revenue of EUR 524 million, up 0.96% year over year on preliminary figures.
  • Adjusted EBITDA fell 18.52% to EUR 66 million; adjusted EBITDA margin narrowed 3.1 percentage points to 12.6%.
  • Free cash flow improved to -EUR 32 million from -EUR 141 million, helped by stricter working-capital management and lower inventory build.
  • Containment & Delivery Systems revenue rose 5.34% to EUR 296 million; adjusted EBITDA climbed 17.31% to EUR 61 million.
  • Management expects a stronger second half; proceeds from Centor and Primary Packaging Plastics sales targeted for debt reduction and refinancing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gerresheimer AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2389406_en) on August 27, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector

GE Healthcare plans to acquire Sofie for about $1 billion, aiming to expand recurring revenue by combining imaging devices with radiodiagnostic agents, in response to weak stock performance and pressure from activist investors.

智通财经2026/09/14 02:36
GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector